ଉଇକିପିଡ଼ିଆ

ଫାଇଜର-ବାୟୋଏନଟେକ କୋଭିଡ-୧୯ଟିକା

ଏହା ଏକ କୋଭିଡ-୧୯ଟିକା ।

ଫାଇଜର-ବାୟୋଏନଟେକ କୋଭିଡ-୧୯ଟିକା (ଇଂରାଜୀ ଭାଷାରେ Pfizer - BioNTech COVID-19 ଟିକା, ଜେନେରିକ୍ ନାମ ଟୋଜିନାମେରାନ୍ ଏବଂ ବେପାର ନାମ କୋମିରନାଟି, ଏକ ପ୍ରକାର କୋଭିଡ-୧୯ ଟିକା ।[୨] କୋଭିଡ-୧୯ ରୋଗରୁ ସୁରକ୍ଷା ଯୋଗାଇବା ପାଇଁ ଏହା ପ୍ରାଧିକରଣ ଉପରେ ନିର୍ଭର କରି ଚାରି, ଏଗାର କିମ୍ବା ପନ୍ଦର ବର୍ଷରୁ ଅଧିକ ବୟସର ଲୋକଙ୍କଠାରେ ବ୍ୟବହୃତ ହୁଏ । [୨] [୨୦] [୨୧] ପ୍ରାରମ୍ଭିକ ଭାବରେ ଏହା ୯୫% ପ୍ରଭାବଶାଳୀ ବୋଲି ଜଣାପଡିଛି । [୨] ଅତି କମରେ ୨୧ ଦିନ ବ୍ୟବଧାନରେ ଦୁଇଟି ଡୋଜ ଟିକା ମାଂସପେଶୀରେ ଇଞ୍ଜେକ୍ସନ ଆକାରରେ ଦିଆଯାଏ ।[୨]

ଫାଇଜର-ବାୟୋଏନଟେକ କୋଭିଡ-୧୯ଟିକା
Vials of the Pfizer–BioNTech COVID‑19 vaccine
Vaccine description
Target diseaseSARS-CoV-2
Type?
Clinical data
PronunciationTozinameran: /ˌtoʊzɪˈnæmərən/ TOH-ZIH-NAM-ƏR-ən
Trade namesComirnaty[୨]
SynonymsBNT162b2, COVID-19 mRNA vaccine (nucleoside-modified)
AHFS/Drugs.commonograph
MedlinePlusa621003
data
Pregnancy
category
Routes of
administration		Intramuscular
Legal status
Legal status

ଅଧିକାଂଶ କ୍ଷେତ୍ରରେ ସାମାନ୍ୟରୁ ମଧ୍ୟମ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟା ହୁଏ ଏବଂ କିଛି ଦିନ ମଧ୍ୟରେ ସମାଧାନ ହୁଏ । [୨] ଇଞ୍ଜେକ୍ସନ ନେଇଥିବା ସ୍ଥାନରେ ଯନ୍ତ୍ରଣା, ଥକାପଣ, ଜ୍ୱର,ତରଳ ଝାଡ଼ା, ମୁଣ୍ଡବିନ୍ଧା ଏବଂ ମାଂସ ପେଶୀ ଯନ୍ତ୍ରଣା ହୋଇପାରେ ।[୨] ବିରଳ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ ଆନାଫାଇଲକ୍ସିସ୍, ଫେସିଆଲ୍ ପାଲସି, ପେରିକାର୍ଡ଼ାଇଟିସ୍ ଏବଂ ମାୟୋକାର୍ଡାଇଟିସ ହୋଇପାରେ। [୨] ଗର୍ଭାବସ୍ଥାରେ ବ୍ୟବହାର ସହିତ କ୍ଷତିର କୌଣସି ପ୍ରମାଣ ମିଳିନାହିଁ । [୨୨] [୨୩] ଏହା ଏକ ଏମଆରଏନଏ (mRNA) ଟିକା, ନ୍ୟୁକ୍ଲିଓସାଇଡ୍-ରୂପାନ୍ତରିତ ଏମଆରଏନଏ (modRNA)କୁ ନେଇ SARS-CoV-2ର ସ୍ପାଇକ୍ ପ୍ରୋଟିନ୍ ଏନକୋଡିଂ କରିଥାଏ, ଯାହା ଲିପିଡ ନାନୋ-ପାର୍ଟିକଲ୍ସରେ ଆବଦ୍ଧ ।[୨୪]

ଏହି ଟିକା ଅକ୍ଟୋବର ୨୦୨୦ ମସିହାରେ ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ଜରୁରୀକାଳୀନ ବ୍ୟବହାର ପ୍ରାଧିକରଣ (EUA) ଗ୍ରହଣ କରିଥିଲା ଏବଂ ଡିସେମ୍ବର ୨୦୨୦ରେ ୟୁରୋପରେ ଚିକିତ୍ସା ପାଇଁ ଅନୁମୋଦନ କରାଯାଇଥିଲା। [୨] [୨୫] ଏହା ଅଗଷ୍ଟ ୨୦୨୧ରେ ଯୁକ୍ତରାଷ୍ଟ୍ରରେ ସମ୍ପୂର୍ଣ୍ଣ ଅନୁମୋଦନ ଲାଭ କରିଥିଲା। [୨୫] ଏହା ୨୦୨୨ ସୁଦ୍ଧା ଅତି କମରେ ୧୫୧ଟି ଦେଶରେ କିଛି ସ୍ତରରେ ବ୍ୟବହାର ପାଇଁ ଅନୁମତି ଦିଆଯାଇଛି। [୨୬] ଏହା ପ୍ରାରମ୍ଭରେ ସରକାରଙ୍କୁ ପ୍ରତି ଡୋଜରେ ୧୫ରୁ ୨୫ ଡଲାରରେ ବିକ୍ରି ହେଉଥିଲା | [୨୭] ଏହାକୁ ଜର୍ମାନୀ କମ୍ପାନୀ ବାୟୋଏନଟେକ ଏବଂ ଆମେରିକୀୟ କମ୍ପାନୀ ଫାଇଜରଦ୍ୱାରା ବିକଶିତ କରାଯାଇଥିଲା | [୨୮] ଏହା ହେଉଛି ପ୍ରଥମ କୋଭିଡ-୧୯ ଟିକା ଯାହାକି ଏକ କଠୋର ନିୟାମକ ପ୍ରାଧିକରଣଦ୍ୱାରା ଅନୁମୋଦିତ । [୨୯] [୩୦] ସେପ୍ଟେମ୍ବର ୨୦୨୧ ସୁଦ୍ଧା ୧.୫ରୁ ଅଧିକ ବିଲିୟନ ଡ଼ୋଜ ବିଭିନ୍ନ ସ୍ଥାନ‌କୁ ପଠାଯାଇଛି ।[୩୧]

ଆଧାର

ସମ୍ପାଦନା
  1. ↑ ୧.୦ ୧.୧ "Comirnaty". Therapeutic Goods Administration (TGA). 25 January 2021. Archived from the original on 1 February 2021. Retrieved 25 January 2021.
  2. ↑ ୨.୦୦ ୨.୦୧ ୨.୦୨ ୨.୦୩ ୨.୦୪ ୨.୦୫ ୨.୦୬ ୨.୦୭ ୨.୦୮ ୨.୦୯ "EPAR2022". European Medicines Agency (EMA). Archived from the original on 19 December 2021. Retrieved 24 October 2021. {{cite web}}: |archive-date= / |archive-url= timestamp mismatch; 18 ଡିସେମ୍ବର 2021 suggested (help)
  3. ↑ "Comirnaty (BNT162b2 [mRNA]) COVID-19 Vaccine Product Information" (PDF). Therapeutic Goods Administration (TGA). Archived from the original on 2 February 2021. Retrieved 25 January 2021.
  4. ↑ "AusPAR: BNT162b2 (mRNA)". Therapeutic Goods Administration (TGA). 23 July 2021. Archived from the original on 24 January 2021. Retrieved 22 October 2021.
  5. ↑ "COVID-19 vaccine: Pfizer Australia - Comirnaty BNT162b2 (mRNA) - approved for use in individuals 12 years and older". Therapeutic Goods Administration (TGA). 27 August 2021. Archived from the original on 23 July 2021. Retrieved 22 October 2021.
  6. ↑ "TGA Provisional Approval of Pfizer-BioNTech COVID-19 vaccine to include 12-15 years age group". Therapeutic Goods Administration (TGA). 23 July 2021. Archived from the original on 22 October 2021. Retrieved 22 October 2021.
  7. ↑ "Regulatory Decision Summary - Comirnaty". Health Canada. Archived from the original on 19 September 2021. Retrieved 18 September 2021.
  8. ↑ "Pfizer-BioNTech Comirnaty COVID-19 vaccine". Health Canada. 9 December 2020. Archived from the original on 5 June 2021. Retrieved 18 September 2021.
  9. ↑ "Drug and vaccine authorizations for COVID-19: List of authorized drugs, vaccines and expanded indications". Health Canada. 17 September 2020. Archived from the original on 24 March 2021. Retrieved 17 September 2021.
  10. ↑ "Regulatory approval of Pfizer/BioNTech vaccine for COVID-19". Medicines and Healthcare products Regulatory Agency (MHRA). 27 September 2021. Archived from the original on 19 January 2021. Retrieved 24 October 2021.
  11. ↑ "Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine". Medicines and Healthcare products Regulatory Agency (MHRA). 10 December 2020. Archived from the original on 15 March 2021. Retrieved 21 December 2020.
  12. ↑ "Conditions of Authorisation for Pfizer/BioNTech COVID-19 vaccine". Medicines and Healthcare products Regulatory Agency (MHRA). 31 December 2020. Archived from the original on 26 February 2021. Retrieved 8 January 2021.
  13. ↑ "Comirnaty". U.S. Food and Drug Administration (FDA). 23 August 2021. STN: 125742. Archived from the original on 3 December 2021. Retrieved 23 August 2021.
  14. ↑ ୧୪.୦ ୧୪.୧ "Pfizer-Biontech COVID-19 Vaccine- bnt162b2 injection, suspension". DailyMed. Archived from the original on 16 November 2020. Retrieved 24 October 2021.
  15. ↑ "FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Children 5 through 11 Years of Age". U.S. Food and Drug Administration (FDA) (Press release). 29 October 2021. Archived from the original on 3 November 2021. Retrieved 4 November 2021.
  16. ↑ "FDA Approves First COVID-19 Vaccine" (Press release). U.S. Food and Drug Administration (FDA). 23 August 2021. Archived from the original on 23 August 2021. Retrieved 23 August 2021.
  17. ↑ "Pfizer–BioNTech COVID-19 Vaccine EUA Letter of Authorization" (PDF). U.S. Food and Drug Administration (FDA). 12 August 2021. Archived from the original on 14 August 2021. Retrieved 13 August 2021.   This article incorporates text from this source, which is in the public domain.
  18. ↑ "Pfizer–BioNTech COVID-19 Vaccine Standing Orders for Administering Vaccine to Persons 12 Years of Age and Older" (PDF). U.S. Centers for Disease Control and Prevention (CDC). 28 September 2021. Archived (PDF) from the original on 2 March 2021. Retrieved 24 October 2021.
  19. ↑ "Pfizer-BioNTech COVID-19 Vaccine- bnt162b2 injection, suspension". DailyMed. Archived from the original on 21 October 2021. Retrieved 24 October 2021.
  20. ↑ "Information for UK recipients on Pfizer/BioNTech COVID-19 vaccine". Medicines and Healthcare products Regulatory Agency (MHRA). 8 December 2020. Archived from the original on 30 May 2021. Retrieved 29 May 2021.
  21. ↑ "Regulatory Decision Summary - Pfizer-BioNTech COVID-19 Vaccine". Health Canada. Archived from the original on 12 May 2021. Retrieved 11 May 2021.
  22. ↑ "Sars-cov-2 mrna (tozinameran) vaccine Use During Pregnancy". Drugs.com (in ଇଂରାଜୀ). Archived from the original on 1 December 2021. Retrieved 29 January 2022.
  23. ↑ Administration, Australian Government Department of Health Therapeutic Goods (25 January 2021). "COMIRNATY". Therapeutic Goods Administration (TGA) (in ଇଂରାଜୀ). Archived from the original on 1 February 2021. Retrieved 29 January 2022.
  24. ↑ Walsh EE, Frenck RW, Falsey AR, Kitchin N, Absalon J, Gurtman A, Lockhart S, Neuzil K, Mulligan MJ, Bailey R, Swanson KA, Li P, Koury K, Kalina W, Cooper D, Fontes-Garfias C, Shi PY, Türeci Ö, Tompkins KR, Lyke KE, Raabe V, Dormitzer PR, Jansen KU, Şahin U, Gruber WC (October 2020). "Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates". The New England Journal of Medicine. 383 (25): 2439–50. doi:10.1056/NEJMoa2027906. PMC 7583697. PMID 33053279. {{cite journal}}: Unknown parameter |displayauthors= ignored (|display-authors= suggested) (help)
  25. ↑ ୨୫.୦ ୨୫.୧ "COVID-19 Vaccine (Pfizer-BioNTech) Monograph for Professionals". Drugs.com (in ଇଂରାଜୀ). Retrieved 29 January 2022.
  26. ↑ Holder, Josh (29 January 2021). "Tracking Coronavirus Vaccinations Around the World". The New York Times. Archived from the original on 22 December 2021. Retrieved 28 January 2022.
  27. ↑ Dyer, Owen (29 January 2021). "Covid-19: Countries are learning what others paid for vaccines". BMJ: n281. doi:10.1136/bmj.n281.
  28. ↑ "What you need to know about BioNTech – the European company behind Pfizer's Covid-19 vaccine". CNBC. 11 November 2020. Archived from the original on 4 March 2021. Retrieved 14 January 2021.
  29. ↑ "UK medicines regulator gives approval for first UK COVID-19 vaccine" (Press release). Medicines and Healthcare products Regulatory Agency (MHRA). 2 December 2020. Archived from the original on 17 March 2021. Retrieved 2 December 2020.
  30. ↑ "UK approves Pfizer/BioNTech Covid vaccine for rollout next week". The Guardian. 2 December 2020. Archived from the original on 2 December 2020. Retrieved 14 December 2020.
  31. ↑ "Pfizer and BioNTech expand collaboration with U.S. to provide 500 million additional COVID-19 vaccine doses at not-for-profit price for donation to poorest countries". 22 September 2021. Archived from the original on 22 September 2021.
"https://or.wikipedia.org/w/index.php?title=ଫାଇଜର-ବାୟୋଏନଟେକ_କୋଭିଡ-୧୯ଟିକା&oldid=487017"ରୁ ଅଣାଯାଇଅଛି